Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 5Small Cell Lung Carcinoma 2Neoplasms 2Lung Diseases 2Laryngeal Neoplasms 2Hemoptysis 2Tuberculosis 1Pulmonary Nodule Cm 1Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1Pneumonia 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lung Diseases, Obstructive 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Disease 1Carcinoma, Bronchogenic 1Bronchitis 1Bronchiectasis 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Bronchoscopy × Clear all
NCT04770675 2022-05-03

Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.

Qmed Consulting A/S

Completed
833 enrolled

Hemoptysis, Lung Diseases, Neoplasms

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed
168 enrolled

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡